New-generation therapy for ANCA-associated vasculitis.

about

Eosinophilic granulomatosis with polyangiitis: an overview.Biologic agents in the treatment of glomerulonephritides.

P2860

Q38269017-DA888F61-D9D5-47B4-8B87-C23BEAF7A30B Q38514894-AD94B721-F8C9-4886-AE00-9165F4F3AE55

P2860

New-generation therapy for ANCA-associated vasculitis.

Item

http://www.wikidata.org/entity/Q38135271

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New-generation therapy for ANCA-associated vasculitis.

@en

type

Item

label

New-generation therapy for ANCA-associated vasculitis.

@en

prefLabel

New-generation therapy for ANCA-associated vasculitis.

@en

P1476

New-generation therapy for ANCA-associated vasculitis.

@en

P2093

David Jayne

http://www.w3.org/2001/XMLSchema#string

P2860

Etanercept plus standard therapy for Wegener's granulomatosis.

Update on the European Vasculitis Study Group trials.

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index

L41. Perspectives on the treatment of giant cell arteritis.

Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

P2888

s10157-013-0855-z

P304

694-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-013-0855-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24013763

http://www.w3.org/2001/XMLSchema#string

New-generation therapy for ANCA-associated vasculitis.

about

P2860

P2860

New-generation therapy for ANCA-associated vasculitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698